Opiant Pharmaceuticals to Participate at the Jefferies 2020 Virtual London Healthcare Conference
Opiant Pharmaceuticals, a specialty pharmaceutical firm focused on addiction and drug overdose treatments, announced that CEO Dr. Roger Crystal will present at the Jefferies 2020 Virtual London Healthcare Conference on November 19, 2020, at 6:45 pm GMT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Opiant Pharmaceuticals, a specialty pharmaceutical firm focused on addiction and drug overdose treatments, announced that CEO Dr. Roger Crystal will present at the Jefferies 2020 Virtual London Healthcare Conference on November 19, 2020, at 6:45 pm GMT. Management will also hold virtual one-on-one meetings throughout the conference, occurring from November 17-19, 2020. Investors and the public can access a live audio webcast of the presentation on the Opiant website, with a replay available for 90 days post-event.
Details
News Market Reaction – OPNT
The recorded move for OPNT in the trading session of this news was +3.35%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA MONICA, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today that its Chief Executive Officer, Dr. Roger Crystal, is scheduled to present its pipeline at the Jefferies 2020 Virtual London Healthcare Conference on Thursday, November 19th, 2020, at 6:45 pm GMT.
Management will be available for virtual one-on-one meetings throughout the conference taking place November 17-19, 2020. Please contact Jefferies sales representatives to participate in their investor conferences and to schedule a virtual one-on-one meeting with our management team.
Investors, analysts, members of the media and the general public are invited to listen to an audio webcast of the presentation that can be accessed via the investor section of the Opiant website: www.opiant.com. A replay of the webcast will be available for 90 days following the event.
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information, visit: www.opiant.com.
Investor Relations Contacts:
Ben Atkins
VP of Corporate Communications and Investor Relations
Batkins@opiant.com
(310) 598-5410
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.